MDxHealth (MDXH) Revenue (2021 - 2026)

MDxHealth (MDXH) has 6 years of Revenue data on file, last reported at $27.4 million in Q1 2026.

• Quarterly Revenue rose 12.74% year-over-year to $27.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.0 billion (up 67616.0% YoY) and the FY2025 annual result came in at $107.9 million, up 19.8% from the prior year.
• Revenue retreated to $27.4 million in Q1 2026 per MDXH's latest filing, from $29.5 million in the prior quarter.
• The five-year high for Revenue was $63.9 billion in Q2 2025, with the low at -$6.1 million in Q2 2022.
• Average Revenue over 5 years is $3.8 billion, with a median of $19.8 million recorded in 2024.
• Year-over-year, Revenue surged 288324.57% in 2025 and gained 12.74% in 2026.
• MDxHealth's Revenue stood at $12.9 million in 2022, then soared by 50.48% to $19.4 million in 2023, then grew by 27.53% to $24.7 million in 2024, then advanced by 19.43% to $29.5 million in 2025, then decreased by 7.31% to $27.4 million in 2026.
• Business Quant data shows MDXH's Revenue at $27.4 million in Q1 2026, $29.5 million in Q4 2025, and $27.4 million in Q3 2025.